Skip to main content
SpringerLink
Log in

Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Summary

The effects of medroxyprogesterone acetate (MPA) on precancerous mammary hyperplastic alveolar nodule (HAN) formation in mice were studied as a possible step to evaluate the anticarcinogenic role of MPA in mammary tumors. One month of subcutaneous pellet implantation of MPA to 6–7 month-old SHN breeding mice resulted in marked decrease and increase in the numbers of HAN and ghosts (the remnants of regressed HAN), respectively. The number of HAN still tended to be smaller in the experimental mice than in the control even 1 month after removal of MPA pellets which had been implanted for 2 months. Serum prolactin level at autopsy was apparently decreased and prolonged estrous vaginal smears observed in the control were replaced by diestrus in the experimental mice. All results indicate that MPA can lasting inhibit HAN formation in mice, and suggest that MPA acts on mammary glands both directly and indirectly through its antiestrogenic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nagasawa H: Hormones and experimental mammary tumors.In Nagasawa H, Abe K (eds): Hormone Related Tumors. Japan Scientific Societies Press/Springer-Verlag, Tokyo/Berlin, 1981, pp 137–163

    Google Scholar 

  2. Matsuzawa A: Progesterone effect on tumor growth and development.In Leung BS (ed): Hormonal Regulation of Mammary Tumors. Vol. I. Steroid Hormones. Eden Press, Montreal, 1982, pp 183–215

    Google Scholar 

  3. Cole P: Estrogens and progesterone in human breast cancer.In Pike MC, Siiteri PK, Welsch CW (eds): Banbury Report 8. Hormones and Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1981, pp 109–113

    Google Scholar 

  4. Løber J, Rose C, Salimtschik M, Mouridsen HT: Treatment of advanced breast cancer with progestins. A review. Acta Obstet Gynecol Scand Suppl 101: 39–46, 1981

    PubMed  Google Scholar 

  5. Vorherr H: Hormones and prostaglandins in relation to breast cancer.In Nagasawa H, Abe K (eds): Hormone Related Tumors. Japan Scientific Societies Press/Springer-Verlag, Tokyo/Berlin, 1981, pp 165–198

    Google Scholar 

  6. Danguy A, Legros N, Devleeschouwer N, Heuson-Stennon JA, Heuson JC: Effects of medroxyprogesterone acetate on growth of DMBA-induced rat mammary tumors: Histopathological and endocrine studies.In Iacobelli S, Di Marco A (eds): Role of Medroxyprogesterone in Endocrine-Related Tumors. Raven Press, New York, 1980, pp 21–28

    Google Scholar 

  7. Izuo M, Iino Y, Endo K: Oral high-dose medroxy-progesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies. Breast Cancer Res Treat 1: 125–130, 1981

    PubMed  Google Scholar 

  8. De Lena M, Brambilla C, Valagussa P, Bonadonna G: High dose medroxyprogesterone acetate (MPA) in metastatic breast cancer previously treated with chemotherapy. Cancer Chemother Pharmacol 2: 175–180, 1979

    PubMed  Google Scholar 

  9. Mattsson W: High dose medroxyprogesterone acetate treatment in advanced mammary carcinoma. A phase II investigation. Acta Radiol Oncol 17: 387–400, 1978

    Google Scholar 

  10. Rannuti F, Di Marco AR, Martoni A, Fruet F, Strocchi E, Burroni P, Rossi AP, Cricca A: Medroxyprogesterone acetate in treatment of metastatic breast cancer: seven years of experience.In Iacobelli S, Di Marco A (eds): Role of Medroxyprogesterone in Endocrine-Related Tumors. Raven Press, New York, 1980, pp 73–92

    Google Scholar 

  11. Nagasawa H, Yanai R, Taniguchi H, Tokuzen R, Nakahara W: Two-way selection of Swiss albino mice for mammary tumorigenesis: Establishment of new two strains (SHN and SLN). J Natl Cancer Inst 57: 425–430, 1976

    PubMed  Google Scholar 

  12. Nagasawa H, Yanai R, Nakajima Y, Namiki H, Kikuyama S, Shiota K: Inhibitory effects of potassium thiocyanate on normal and neoplastic mammary development in female mice. Europ J Cancer 16: 473–480, 1980

    Google Scholar 

  13. Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: A review. Cancer Res 37: 951–963, 1977

    PubMed  Google Scholar 

  14. Nagasawa H: Role of prolactin or placental lactogen in mammary tumor development in experimental animals.In Leung BS (ed): Hormonal Regulation of Mammary Tumors. Vol. II. Peptide and Other Hormones. Eden Press, Montreal, 1982, pp 1–24

    Google Scholar 

  15. Jabara AG, Anderson PS: Effects of progesterone on mammary carcinogenesis when various doses of DMBA were applied directly to rat mammae. Pathology 14: 313–316, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Animal Research Laboratory, Meiji University, 214, Tama-ku, Kawasaki, Kanagawa, Japan

    Hiroshi Nagasawa, Madoka Fujii & Kikumi Hagiwara

Authors
  1. Hiroshi Nagasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madoka Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kikumi Hagiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by a grant-in-aid for Cancer Research from the Ministry of Education, Science and Culture, Japan (No. 59010046).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagasawa, H., Fujii, M. & Hagiwara, K. Inhibition by medroxyprogesterone acetate of precancerous mammary hyperplastic alveolar nodule formation in mice. Breast Cancer Res Tr 5, 31–36 (1985). https://doi.org/10.1007/BF01807647

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807647

Keywords

Search

Navigation